CN Stock MarketDetailed Quotes
002900 Harbin Medisan Pharmaceutical
- 9.53
- -0.15-1.55%
Market Closed Jan 15 15:00 CST
3.02BMarket Cap55.73P/E (TTM)
9.72High9.48Low24.51KlotVolume9.72Open9.68Pre Close23.40MTurnover1.42%Turnover Ratio40.90P/E (Static)316.39MShares14.2052wk High1.41P/B1.65BFloat Cap6.5452wk Low10.65Limit Up173.16MShs Float36.30Historical High8.71Limit Down2.48%Amplitude6.47Historical Low0.20Dividend TTM9.55Avg Price13.24KlotAsk2.10%Div YieldTTM100Lot Size10.65KlotBid
Harbin Medisan Pharmaceutical Key Stats
All
YOY
| (Q9)Sep 30, 2024 | (Q6)Jun 30, 2024 | (Q3)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q9)Sep 30, 2023 | (Q6)Jun 30, 2023 | (Q3)Mar 31, 2023 | (FY)Dec 31, 2022 | (Q9)Sep 30, 2022 | (Q6)Jun 30, 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | ||||||||||
| Goods sale service render cash | -15.74%806.73M | -22.22%509.07M | -16.56%260.64M | 10.56%1.27B | 17.34%957.42M | 27.25%654.5M | 22.72%312.37M | 11.58%1.15B | 5.77%815.9M | 1.64%514.33M |
| Refunds of taxes and levies | -41.84%5.5M | -71.28%2.28M | -51.07%2.02M | 4.71%12.21M | -16.97%9.45M | -30.38%7.92M | 139.96%4.12M | -53.22%11.66M | -53.00%11.38M | -45.70%11.38M |
| Cash received relating to other operating activities | 86.22%55.84M | 89.69%47.26M | -3.71%18.93M | 8.87%45.58M | 0.41%29.99M | 52.63%24.91M | 386.33%19.66M | 9.33%41.87M | 55.32%29.87M | 36.66%16.32M |
| Cash inflows from operating activities | -12.92%868.07M | -18.73%558.61M | -16.23%281.59M | 10.44%1.33B | 16.30%996.85M | 26.81%687.33M | 29.13%336.14M | 10.02%1.2B | 5.19%857.15M | 0.58%542.03M |
| Goods services cash paid | 13.32%439.77M | 31.49%296.22M | 28.16%148.52M | 64.59%521.79M | 62.48%388.09M | 53.12%225.28M | 26.52%115.88M | 16.33%317.03M | 10.45%238.86M | -3.83%147.13M |
| Staff behalf paid | 24.84%230.11M | 26.23%153.33M | 38.09%78.08M | 34.89%258.37M | 34.08%184.32M | 33.22%121.48M | 24.01%56.54M | 7.16%191.54M | 13.37%137.47M | 13.21%91.19M |
| All taxes paid | -53.53%37.67M | -56.67%26.86M | -64.84%11.52M | 6.99%104.33M | 9.16%81.07M | 27.23%62M | 33.78%32.75M | -2.16%97.52M | -4.73%74.26M | -6.68%48.73M |
| Cash paid relating to other operating activities | -34.92%205.64M | -39.38%145M | -24.37%79.24M | -9.73%407.56M | -8.96%316M | 6.59%239.21M | -1.54%104.77M | -18.55%451.48M | -16.46%347.1M | -17.52%224.43M |
| Cash outflows from operating activities | -5.81%913.19M | -4.10%621.42M | 2.39%317.35M | 22.17%1.29B | 21.54%969.48M | 26.69%647.97M | 15.62%309.94M | -4.31%1.06B | -4.00%797.69M | -8.31%511.47M |
| Net cash flows from operating activities | -264.82%-45.12M | -259.56%-62.81M | -236.48%-35.76M | -75.32%35.69M | -53.96%27.38M | 28.81%39.37M | 437.45%26.21M | 1,254.01%144.64M | 468.89%59.46M | 261.31%30.56M |
| Investing cash flow | ||||||||||
| Cash received from disposal of investments | 165.80%205M | 92.56%110M | --0 | -81.27%107.13M | -86.28%77.13M | -89.61%57.13M | -96.66%16.7M | -35.44%572M | -10.22%562M | 72.41%550M |
| Cash received from returns on investments | 161.77%20.77M | 176.84%19.55M | --0 | -1.03%8.12M | 15.89%7.93M | 4.38%7.06M | -73.72%1.3M | -48.35%8.21M | -40.04%6.84M | 15.04%6.76M |
| Net cash received from disposal of fix assets、 intangible assets 、other long-term asset | -91.04%19.65K | -98.72%2.62K | -96.87%2.24K | -18.71%219.75K | 31.81%219.18K | 295.99%204.02K | --71.37K | -97.67%270.33K | -98.57%166.29K | -99.34%51.52K |
| Cash inflows from investing activities | 164.76%225.79M | 101.19%129.55M | -99.99%2.24K | -80.11%115.47M | -85.01%85.28M | -88.44%64.39M | -96.42%18.06M | -36.46%580.48M | -12.33%569.01M | 67.35%556.82M |
| Cash paid to acquire fixed assets intangible assets and other long-term assets | 25.42%257.97M | 54.26%182.95M | 6.79%65.56M | 235.76%299.58M | 268.16%205.68M | 258.43%118.6M | 692.70%61.39M | 20.66%89.22M | 12.62%55.87M | -0.56%33.09M |
| Cash paid to acquire investments | 205.75%231.08M | 755.00%171M | --30M | -16.07%60.43M | 4.97%75.58M | -66.67%20M | --0 | -93.54%72M | -91.53%72M | -90.10%60M |
| Net cash paid to acquire subsidiaries and other business units | ---- | ---- | ---- | --15.98M | ---- | ---- | ---- | --0 | ---- | ---- |
| Cash paid relating to other investing activities | --15M | --15M | ---- | ---- | --0 | --0 | ---- | ---- | ---- | ---- |
| Cash outflows from investing activities | 79.21%504.05M | 166.19%368.95M | 55.66%95.56M | 133.21%375.99M | 119.96%281.26M | 48.89%138.6M | 6.31%61.39M | -86.47%161.22M | -85.85%127.87M | -85.53%93.09M |
| Net cash flows from investing activities | -41.98%-278.27M | -222.59%-239.4M | -120.54%-95.56M | -162.14%-260.52M | -144.43%-195.98M | -116.00%-74.21M | -109.69%-43.33M | 250.68%419.25M | 273.42%441.14M | 249.30%463.73M |
| Financing cash flow | ||||||||||
| Cash from borrowing | 147.47%680.54M | 147.81%656.7M | 113.89%385M | -35.03%280M | -36.19%275M | -38.52%265M | -47.21%180M | -8.61%431M | 4.71%431M | 10.51%431M |
| Cash received relating to other financing activities | 15,820.26%211.74M | 15,812.47%211.64M | --3.55M | -97.19%1.33M | -97.19%1.33M | --1.33M | ---- | 3,126.72%47.29M | 3,126.72%47.29M | ---- |
| Cash inflows from financing activities | 222.90%892.28M | 226.04%868.34M | 115.86%388.55M | -41.18%281.33M | -42.23%276.33M | -38.21%266.33M | -47.21%180M | 1.10%478.29M | 15.79%478.29M | 10.10%431M |
| Borrowing repayment | 105.33%472.54M | 110.06%462.47M | 38.39%180.07M | -12.97%235.17M | 9.51%230.13M | 4.82%220.16M | 18.29%130.12M | 0.25%270.21M | -22.02%210.15M | -8.49%210.03M |
| Dividend interest payment | 152.72%97.61M | 153.12%91.77M | 40.98%3.45M | -62.47%41.04M | -63.87%38.62M | -65.19%36.25M | -2.32%2.44M | 218.64%109.34M | 232.46%106.9M | 1,676.20%104.16M |
| Cash payments relating to other financing activities | -32.60%17.18M | -62.85%7.85M | 1.13%576.25K | -90.19%20.2M | -87.55%25.49M | -89.65%21.12M | -99.72%569.8K | -3.32%205.86M | 1.63%204.68M | 0.31%203.96M |
| Cash outflows from financing activities | 99.61%587.32M | 102.53%562.08M | 38.28%184.09M | -49.37%296.41M | -43.60%294.24M | -46.44%277.54M | -57.65%133.13M | 13.28%585.41M | 3.71%521.73M | 18.11%518.15M |
| Net cash flows from financing activities | 1,802.66%304.96M | 2,833.11%306.26M | 336.26%204.46M | 85.92%-15.08M | 58.77%-17.91M | 87.14%-11.21M | 76.17%46.87M | -145.08%-107.12M | 51.73%-43.44M | -84.47%-87.15M |
| Net cash flow | ||||||||||
| Net increase in cash and cash equivalents | 90.12%-18.43M | 108.78%4.04M | 145.90%73.14M | -152.52%-239.91M | -140.80%-186.52M | -111.31%-46.05M | -93.62%29.74M | 236.56%456.77M | 226.82%457.16M | 208.05%407.14M |
| Add:Begin period cash and cash equivalents | -30.67%542.36M | -30.67%542.36M | -30.67%542.36M | 140.33%782.27M | 140.33%782.27M | 140.33%782.27M | 140.11%782.27M | -50.68%325.5M | -50.68%325.5M | -50.68%325.5M |
| End period cash equivalent | -12.06%523.93M | -25.78%546.4M | -24.20%615.5M | -30.67%542.36M | -23.88%595.75M | 0.49%736.22M | 2.55%812.01M | 140.33%782.27M | 161.34%782.66M | 158.72%732.64M |
| Currency Unit | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY |
| Accounting Standards | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) |
| Audit Opinions | -- | -- | -- | Unqualified opinion | -- | -- | -- | Unqualified opinion | -- | -- |
| Auditor | -- | -- | -- | ZTE Caiguanghua Certified Public Accountants Co., Ltd. (Special General Partnership) | -- | -- | -- | ZTE Caiguanghua Certified Public Accountants Co., Ltd. (Special General Partnership) | -- | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.
Heat List
CN
Overall
Symbol
Price
% Chg
No Data
